Lucianò, A.M.; Perciballi, E.; Fiore, M.; Del Bufalo, D.; Tata, A.M.
The Combination of the M2 Muscarinic Receptor Agonist and Chemotherapy Affects Drug Resistance in Neuroblastoma Cells. Int. J. Mol. Sci. 2020, 21, 8433.
https://doi.org/10.3390/ijms21228433
AMA Style
Lucianò AM, Perciballi E, Fiore M, Del Bufalo D, Tata AM.
The Combination of the M2 Muscarinic Receptor Agonist and Chemotherapy Affects Drug Resistance in Neuroblastoma Cells. International Journal of Molecular Sciences. 2020; 21(22):8433.
https://doi.org/10.3390/ijms21228433
Chicago/Turabian Style
Lucianò, Anna Maria, Elisa Perciballi, Mario Fiore, Donatella Del Bufalo, and Ada Maria Tata.
2020. "The Combination of the M2 Muscarinic Receptor Agonist and Chemotherapy Affects Drug Resistance in Neuroblastoma Cells" International Journal of Molecular Sciences 21, no. 22: 8433.
https://doi.org/10.3390/ijms21228433
APA Style
Lucianò, A. M., Perciballi, E., Fiore, M., Del Bufalo, D., & Tata, A. M.
(2020). The Combination of the M2 Muscarinic Receptor Agonist and Chemotherapy Affects Drug Resistance in Neuroblastoma Cells. International Journal of Molecular Sciences, 21(22), 8433.
https://doi.org/10.3390/ijms21228433